The Kidney Care Access Protection Act aims to improve access to innovative treatments for individuals with end-stage renal disease (ESRD) under Medicare, enhancing the overall quality of kidney care. The legislation introduces key provisions that modify how Medicare compensates kidney-related treatments, ensuring patients benefit from new therapies. A significant aspect of the act is the extension of financial support for new renal dialysis drugs and devices.